Gilead Sciences Aktie

63.33 CHF -2.25CHF -3.43%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
The Vanguard Group, Inc. 7.83
Capital Research & Management Co. (Global Investors) 6.15
BlackRock Fund Advisors 5.12
SSgA Funds Management, Inc. 4.61
Geode Capital Management LLC 1.39
Dodge & Cox 1.36
Northern Trust Investments, Inc.(Investment Management) 1.35
Capital Research & Management Co. (World Investors) 1.28
Invesco Capital Management LLC 1.04
Norges Bank Investment Management 1.00
Renaissance Technologies LLC 1.00
T. Rowe Price Associates, Inc. (Investment Management) 0.95
Fidelity Management & Research Co. 0.93
Sanders Capital LLC 0.91
AllianceBernstein LP 0.87

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 0 0 0 0 0
Umsatz pro Mitarbeiter in Mio. EUR 355'571'428'571'429.00 4'004'625.00 336'855'555'555'556.00 26'135.00 201'945'454'545'455.00

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 17'714 24'763 20'445 31'823 35'836
Summe Anlagevermögen 27'845 40'714 45'233 53'984 48'709
Summe Aktiva 34'664 51'839 56'977 70'283 63'675

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 12'419 22'180 26'346 33'542 27'322
Summe Fremdkapital 18'845 32'726 37'614 49'782 42'141
Summe Eigenkapital 15'819 19'113 19'363 20'501 21'534
Summe Passiva 34'664 51'839 56'977 70'283 63'675

Adresse

333 Lakeside Drive, 94404 Foster City
Telefon 16505743000
Fax 16505789264
Internet http://www.gilead.com

Management

Andrew D. Dickinson
Executive VP-Corporate Development & Strategy
Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Daniel O'Day, MBA
Chairman & Chief Executive Officer
Diana Brainard, MD
Senior VP-HIV & Emerging Viral Infections
Gayle Edlund Wilson
Independent Director
George Pratt Shultz, PhD
Director-Emeritus
Gregg H. Alton
Chief Patient Officer
Harish M. Manwani
Independent Director
Jacqueline K. Barton, PhD
Independent Director
Johanna Mercier
Chief Commercial Officer
John Francis Cogan, PhD
Lead Independent Director
Jyoti Mehra
Executive Vice President-Human Resources
Kelly A. Kramer
Independent Director
Kevin E. Lofton
Independent Director
Michael Louie
Vice President-Information Systems
Per Wold-Olsen, MBA
Independent Director
Richard J. Whitley, MD
Independent Director
Robin L. Washington MBA, CPA
CFO, Chief Accounting Officer & Executive VP
Sung Lee
Vice President-Investor Relations
William A. Lee, PhD
Executive Vice President-Research

Eintrag hinzufügen